AstraZeneca (AZN) Tops Q1 EPS by 23c
Tweet Send to a FriendGet Alerts AZN Hot Sheet
Trade AZN Now!
AstraZeneca (NYSE: AZN) reported Q1 EPS of $2.23, $0.23 better than the analyst estimate of $2.00. Revenue for the quarter came in at $8.29 billion versus the consensus estimate of $8.43 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.C. Penney Co., Inc. (JCP) Posts Q1 Loss of $1.31/Share; Comps Down 16.6%
- Natus Medical (BABY) Tops Q1 EPS by 4c; Nudges FY13 EPS Outlook Higher
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Hot Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
